The Probiotic VSL#3(®) Does Not Seem to Be Efficacious for the Treatment of Gastrointestinal Symptomatology of Patients with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Gastrointestinal symptomatology is frequent among patients with fibromyalgia, which increases disease burden and lacks specific treatment, either pharmacological or non-pharmacological. We aimed to evaluate the efficacy and tolerability of a multi-strain probiotic, VSL#3(®), for the treatment of fib...

Descripción completa

Detalles Bibliográficos
Autores principales: Calandre, Elena P., Hidalgo-Tallon, Javier, Molina-Barea, Rocio, Rico-Villademoros, Fernando, Molina-Hidalgo, Cristina, Garcia-Leiva, Juan M., Carrillo-Izquierdo, Maria Dolores, Slim, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537098/
https://www.ncbi.nlm.nih.gov/pubmed/34681287
http://dx.doi.org/10.3390/ph14101063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537098/
https://www.ncbi.nlm.nih.gov/pubmed/34681287
http://dx.doi.org/10.3390/ph14101063

Ejemplares similares